HCA HCA Healthcare, Inc. Common Stock

NYSE · Health Care · Wyświetl na SEC EDGAR ↗
$420,53
Cena · Sie 19, 2026
Dane fundamentalne na dzień Lip 28, 2026

O HCA Healthcare, Inc. Common Stock Przegląd firmy z Wikipedii

HCA Healthcare, Inc. is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.

Czytaj więcej

HCA Healthcare, Inc. (historically known as Hospital Corporation of America) is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.

History

Early years

The Hospital Corporation of America (HCA) was founded in 1968 in Nashville, Tennessee, by Thomas F. Frist Sr., Thomas F. Frist Jr. and Jack C. Massey. The founders envisioned a company that would bring together hospitals to deliver patient-focused care while using the combined resources of the organization to strengthen hospitals and improve the practice of medicine. The company began with Nashville's Park View Hospital, which the elder Frist had founded in 1960 with other doctors and where he was serving as chief executive.

The company included 11 hospitals when it filed its initial public offering on the New York Stock Exchange (NYSE) in 1969 and had 26 hospitals and 3,000 beds by the end of the year.

Growth and merger

The 1970s were characterized by rapid growth in the industry and for HCA Healthcare. In the early 1980s, the focus shifted to consolidation with HCA Healthcare acquiring General Care Corporation, General Health Services, Hospital Affiliates International and Health Care Corporation. By the end of 1981, the company operated 349 hospitals with more than 49,000 beds. Operating revenues had grown to $2.4 billion.

In 1987, HCA Healthcare, which had grown to operate 463 hospitals (255 owned and 208 managed), spun off HealthTrust, a privately owned, 104-hospital company. Believing its stock was undervalued, the company completed a $5.1 billion leveraged management buyout led by chairman Thomas F. Frist Jr. in 1988. HCA Healthcare re-emerged as a public company in 1992.

In February 1994, HCA Healthcare merged with Louisville, Kentucky-based Columbia Hospital Corporation, which earlier had acquired 73 hospitals of Galen Health Care from Humana,

to form Columbia/HCA Healthcare Corporation. Related names of note include HCA International and Health Corporation of America.

Columbia Hospital Corporation

In 1988, Rick Scott and Richard Rainwater each put up $125,000 in working capital in their new company, Columbia Hospital Corporation; they borrowed the remaining money needed to purchase two struggling hospitals in El Paso for $60 million. Then they acquired a neighboring hospital and shut it down. Within a year, the remaining two were doing much better. By the end of 1989, Columbia Hospital Corporation owned four hospitals with a total of 833 beds.

In 1992, Columbia made a stock purchase of Basic American Medical, which owned eight hospitals, primarily in southwestern Florida. In September 1993, Columbia did another stock purchase, worth $3.4 billion, of Galen Healthcare, which had been spun off by Humana Inc. several months earlier. At the time, Galen had approximately 90 hospitals. After the purchase, Galen stockholders had 82% of the stock in the combined company, with Scott still running the company.

Recent history

On November 17, 2006, HCA became a private company for the third time when it completed a merger in which the company was acquired by a private investor group including affiliates of Kohlberg Kravis Roberts and Bain Capital, together with Merrill Lynch and HCA Healthcare founder Thomas F. Frist Jr. The total transaction was valued at approximately $33 billion, making it the largest leveraged buyout in history at the time, eclipsing the 1989 buyout of RJR Nabisco.

In May 2010, HCA announced that the corporation would once again go public with an expected $4.6-billion IPO as HCA Holdings, Inc. In March 2011, HCA sold 126.2 million shares for $30 each, raising about $3.79 billion, at that time, the largest private-equity backed IPO in U.S. history. In May 2017, the corporation was renamed HCA Healthcare.

In December 2018, a historical marker was installed in the parking lot of HCA's Sarah Cannon Cancer Center in Nashville, formerly the location of HCA's first hospital, Park View Hospital.

In 2018, the company was ranked No. 67 in the 2019 Fortune 500 list of the largest United States corporations by total revenue.

In May 2021, the company finalized a deal with Google to develop healthcare algorithms using patient records. In August 2021, HCA announced a deal with venture capital firm General Catalyst to develop digital solutions to streamline workflows and improve patient care; as part of the deal, HCA sold its healthcare app development firm PatientKeeper to General Catalyst's portfolio company Commure.

In April 2022, HCA Healthcare announced a $1.5 million partnership with Florida International University's Nicole Wertheim college of Nursing and Health Sciences, to expand its facilities to address the national nursing shortage.

In October 2022, LCMC Health in partnership with Tulane University announced that it would acquire Tulane Medical Center, Lakeview Regional Medical Center, and Tulane Lakeside Hospital from HCA for $150 million pending regulatory approval.

In March 2024, it was announced HCA had completed the sale of West Hills Hospital and Medical Center and related assets in Los Angeles, California to UCLA Health, for an undisclosed amount.

Facilities

United States

As of 2024, HCA has 186 hospitals. They also report operating more than 2,400 additional sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics located in 20 U.S. states and in the United Kingdom. A significant portion of those hospitals are situated in Florida and Texas. As of 2022, HCA had 47 hospitals and 31 surgery centers in Florida, and 45 hospitals and 632 affiliated sites of care in Texas. In 2021, it announced plans to build 3 new hospitals in Florida. In 2022, The Dallas Morning News reported that HCA will build 5 new hospitals in Texas. They also have a strong presence in Tennessee, where it began. HCA had 13 hospitals there as of 2019.

Between 2003 and 2017, HCA did not enter any new markets. However, in July 2007, HCA sold its hospitals in Switzerland.

In 2017, HCA acquired the Memorial University Medical Center in Savannah, Georgia. That same year, they acquired three Houston, Texas, hospitals from Tenet Healthcare.

In 2019 they purchased Mission Health System which operates hospitals in North Carolina.

In January 2020, HCA Healthcare acquired Valify, a healthcare cost-management company. In May 2020, HCA acquired 49-bed Shands Starke (Fla.) Regional Medical Center and 25-bed Shands Live Oak (Fla.) Regional Medical Center from CHS. HCA is operating the two facilities as off-campus emergency departments of Lake City (Fla.) Medical Center and North Florida Regional Medical Center in Gainesville. Later that year, it signed an agreement to sell Garden Park Medical Center to Singing River Health System.

In 2021, HCA sold Redmond Regional Medical Center to AdventHealth for $635M, and four other Georgia hospitals to Piedmont Healthcare for $950 million. They also announced the acquisition of Meadows Regional Medical Center.

United Kingdom

HCA International, the UK arm of Hospital Corporation of America, "caters for around half of all private patients in London." The main hospital sites within the United Kingdom it operates include:

It opened urgent care walk-in centres at London Bridge Hospital and the Portland Hospital in March 2018. It claims that patients, on average, wait just seven minutes to see a nurse and 17 minutes to see a doctor. In February 2022, outsourced cleaning staff at London Bridge Hospital reported a lack of PPE, no access to sick pay, a lack of training and no prior warning about which rooms may be contaminated with the virus through the COVID-19 pandemic.

The Princess Grace Hospital specializes in breast cancer and surgery, aided by Kefah Mokbel and Nick Perry who, in 2005, founded The London Breast Institute.

The company opened The Harborne Hospital, a newly built private hospital located close to the Queen Elizabeth Hospital, Birmingham, in February 2024.

Significant areas of operation

Medical education

In recent years, HCA Healthcare has become a significant provider of clinical and medical education. It is the largest sponsor of graduate medical education programs in the U.S., with 56 teaching hospitals in 14 states, primarily in regions with a deficit of physician training programs. The company includes Research College of Nursing and Mercy School of Nursing, and has several advanced nursing simulation training centers. In early 2020, it completed the purchase of a majority stake in Galen College of Nursing, which operates 21 campuses in 12 states, offering Bachelor of Science and Associate of Science nursing degrees.

Controversies

Medicare billing practices lawsuit

In 1993, lawsuits were filed against HCA by former employees who alleged that the company had engaged in questionable Medicare billing practices. In 1997, with a federal investigation by the FBI, the IRS and the Department of Health and Human Services in its early stages, the Columbia/HCA board of directors forced Rick Scott to resign as chairman and CEO amid growing evidence that the company "had kept two sets of books, one to show the government and one with actual expenses listed." Thomas Frist, a co-founder of HCA and brother of U.S. Senator Bill Frist, returned to the company as CEO in 1997 and called on longtime friend and colleague Jack O. Bovender Jr. to help him turn the company around.

The federal probe culminated in 2003 with "the government receiving a total of over $2 billion in criminal fines and civil penalties for systematically defrauding federal health care programs." Columbia/HCA pleaded guilty to 14 felonies and admitted to systematically overcharging the government. The federal probe has been referred to as the longest and costliest investigation for health-care fraud in U.S. history.

2005 insider trading suit

In July 2005, U.S. Senator Bill Frist sold all of his HCA shares, which were held in a blind trust, two weeks before disappointing earnings sent the stock on a 9-point plunge. At the time, Frist was considering a run for president and said that he had sold his shares to avoid the appearance of a conflict of interest. When the company disclosed that other executives had also sold their shares during that same time, shareholders alleged that the company had made false claims about its profits to drive up the price, which then fell when the company reported disappointing financial results. Eleven of HCA's senior officers were sued for accounting fraud and insider trading. HCA settled the lawsuit in August 2007, agreeing to pay $20 million to the shareholders but admitting no wrongdoing, and no charges were brought.

COVID-19 PPE

During the COVID-19 pandemic in the United States, HCA hospital nurses and other workers spoke out about the lack of PPE. In April 2020, there was an outcry against HCA following the deaths of two nurses Celia Yap-Banago and Rosa Luna who worked at HCA hospitals in Kansas City and California and had contracted coronavirus, despite the alarm having been raised about the lack of PPE at work.

Mission Hospital Acquisition Complaints

On December 14, 2023, the North Carolina Attorney General sued HCA for violating the terms of an agreement that allowed HCA to purchase Mission Health.

On February 13, 2024, HCA Healthcare denied the allegations and asked a judge to dismiss the lawsuit by the Attorney General, and in return the hospital network filed a counterclaim against the Attorney General.

Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗

Wikidata ↗

HCA Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy

Cena
$420.53
Kapitalizacja Rynkowa
$94.45B
P/E (TTM)
14.8
EPS (TTM)
$28.33
Przychody (TTM)
$75.60B
Stopa dywidendy
0.72%
ROE
-159.1%
D/E Dług/Kapitał
-6.9
Zakres 52 tyg.
$354 – $557

HCA Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok

Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS

Przychody i Zysk Netto $75.60B
10-point trend, +82.2%
2016-12-31 2025-12-31
EPS $28.33
10-point trend, +288.1%
2016-12-31 2025-12-31
Wolny przepływ pieniężny $7.69B
10-point trend, +165.9%
2016-12-31 2025-12-31
Marże 9.0%

Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?

Wskaźnik
Trend 5-letni
HCA
Mediana porównawcza
P/E (TTM)
5-point trend, +35.7%
14.8
20.3
P/S (TTM)
5-point trend, +3.8%
1.2
1.1
P/B
5-point trend, +79.3%
-15.7
4.5
EV / EBITDA
5-point trend, +5.5%
38.3
Price / FCF (Cena / FCF)
5-point trend, -6.5%
12.3

Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC

Wskaźnik
Trend 5-letni
HCA
Mediana porównawcza
Net Profit Margin (Marża Zysku Netto)
5-point trend, -24.2%
9.0%
7.4%
ROA
5-point trend, -20.3%
11.3%
6.6%
ROE
5-point trend, +95.9%
-159.1%
23.2%

Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu

Wskaźnik
Trend 5-letni
HCA
Mediana porównawcza
Debt / Equity (Dług / Kapitał Własny)
5-point trend, +81.4%
-6.9
Current Ratio (Wskaźnik bieżący)
5-point trend, -31.7%
1.0
1.2
Quick Ratio (Wskaźnik Szybkości)
5-point trend, -26.9%
0.7

Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni

Wskaźnik
Trend 5-letni
HCA
Mediana porównawcza
Revenue YoY (Przychody R/R)
5-point trend, +28.7%
7.1%
Revenue CAGR 3Y (Przychody CAGR 3L)
5-point trend, +28.7%
7.9%
Revenue CAGR 5Y (Przychody CAGR 5L)
5-point trend, +28.7%
8.0%
EPS YoY
5-point trend, +33.9%
28.8%
Net Income YoY (Zysk Netto R/R)
5-point trend, -2.5%
17.8%

Wskaźniki na akcję EPS, wartość księgowa na akcję, przepływy pieniężne na akcję, dywidenda na akcję

Wskaźnik
Trend 5-letni
HCA
Mediana porównawcza
EPS (Diluted) (EPS (Rozwodniony))
5-point trend, +33.9%
$28.33

Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności

Wskaźnik
Trend 5-letni
HCA
Mediana porównawcza
Payout Ratio (Wskaźnik Wypłaty Dywidendy)
5-point trend, +11.6%
10.0%

Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR

Stopa Dywidendy
0.72%
Wskaźnik Wypłaty Dywidendy
10.0%
CAGR dywidendy 5-letni
Data ex-dywidendyKwota
16 czerwca 2026$0,7800
17 marca 2026$0,7800
15 grudnia 2025$0,7200
16 września 2025$0,7200
16 czerwca 2025$0,7200
17 marca 2025$0,7200
13 grudnia 2024$0,6600
16 września 2024$0,6600
14 czerwca 2024$0,6600
14 marca 2024$0,6600
13 grudnia 2023$0,6000
14 września 2023$0,6000
15 czerwca 2023$0,6000
16 marca 2023$0,6000
13 grudnia 2022$0,5600
15 września 2022$0,5600
15 czerwca 2022$0,5600
16 marca 2022$0,5600
13 grudnia 2021$0,4800
15 września 2021$0,4800

HCA Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu

KUP 30 analityków
  • Mocne kupno 6 20,0%
  • Kup 11 36,7%
  • Trzymaj 12 40,0%
  • Sprzedaj 1 3,3%
  • Mocna sprzedaż 0 0,0%

12-miesięczny cel cenowy

21 analityków · 2026-08-17
Średni cel $450.00 +7,0%
Średnia cel $454.57 +8,1%

Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników

Średnie zaskoczenie
0.49%
Okres EPS Actual EPS Szacowany Niespodzianka
30 czerwca 2026 $7.62 $7.54 0.08%
31 marca 2026 $7.15 $7.21 -0.06%
31 grudnia 2025 $8.14 $7.53 0.61%
30 września 2025 $6.96 $5.77 1.2%
30 czerwca 2025 $6.83 $6.31 0.52%
31 marca 2025 $6.45 $5.84 0.61%

Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora

Ticker Kapitalizacja Rynkowa P/E Przychody r/r Marża Netto ROE Marża brutto
HCA $104.86B 16.5 7.1% 9.0% -159.1%
THC $17.28B 12.8 3.1% 11.1% 56.4%
EHC $10.61B 19.2 10.5% 9.5% 25.1%
ENSG $10.12B 29.8 18.7% 6.8% 16.9%
UHS 9.4 9.7% 8.6% 21.4%
PACS $6.01B 31.5 29.3% 3.6% 23.1%
CON $2.53B 15.1 13.9% 7.7% 49.8%
BKD $2.57B -9.6 2.2% -8.2% -313.2% 26.2%
ACHC $1.28B -1.2 5.0% -33.3% -43.9%
SNDA $612M -7.7 25.2% -18.6% -197.2%

Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne

Rachunek zysków i strat 12
Dane roczne Rachunek zysków i strat dla HCA
Wskaźnik Trend 2025202420232022202120202019201820172016
Revenue 10-point trend, +82.2% $75.60B $70.60B $64.97B $60.23B $58.75B $51.53B $51.34B $46.68B $43.61B $41.49B
SG&A Expense 10-point trend, +59.8% $548M $421M $353M $307M $337M $416M $370M $344M $340M $343M
Operating Expenses 10-point trend, +79.3% $65.77B $62.08B $57.26B $51.65B $48.92B $46.10B $46.09B $41.34B $39.23B $36.68B
Interest Expense 10-point trend, +31.7% $2.25B $2.06B $1.94B $1.74B $1.57B $1.58B $1.82B $1.75B $1.69B $1.71B
Pretax Income 10-point trend, +104.4% $9.83B $8.52B $7.71B $8.58B $9.83B $5.43B $5.24B $5.33B $4.38B $4.81B
Income Tax 10-point trend, +48.8% $2.05B $1.87B $1.61B $1.75B $2.11B $1.04B $1.10B $946M $1.64B $1.38B
Net Income 10-point trend, +134.7% $6.78B $5.76B $5.24B $5.64B $6.96B $3.75B $3.50B $3.79B $2.22B $2.89B
EPS (Basic) 10-point trend, +281.1% $28.70 $22.27 $19.25 $19.43 $21.52 $11.10 $10.27 $10.90 $6.12 $7.53
EPS (Diluted) 10-point trend, +288.1% $28.33 $22.00 $18.97 $19.15 $21.16 $10.93 $10.07 $10.66 $5.95 $7.30
Shares (Basic) 10-point trend, -38.4% 236,413,000 258,603,000 272,404,000 290,348,000 323,315,000 338,274,000 341,210,000 347,297,000 362,305,000 383,591,000
Shares (Diluted) 10-point trend, -39.5% 239,495,000 261,806,000 276,412,000 294,666,000 328,752,000 343,605,000 348,226,000 355,303,000 372,221,000 395,851,000
EBITDA 10-point trend, +79.2% $3.52B $3.31B $3.08B $2.97B $2.85B $2.72B $2.60B $2.28B $2.13B $1.97B
Bilans 22
Dane roczne Bilans dla HCA
Wskaźnik Trend 2025202420232022202120202019201820172016
Cash & Equivalents 10-point trend, +61.0% $1.04B $1.93B $935M $908M $1.45B $1.79B $621M $502M $732M $646M
Short-term Investments 5-point trend, +136.7% · · · · · $116M $147M $47M $54M $49M
Receivables 10-point trend, +86.5% $10.87B $10.75B $9.96B $8.89B $8.10B $7.05B $7.38B $6.79B $6.50B $5.83B
Inventory 10-point trend, +9.9% $1.65B $1.74B $2.02B $2.07B $1.99B $2.02B $1.85B $1.73B $1.57B $1.50B
Other Current Assets 10-point trend, +100.2% $2.22B $1.99B $2.01B $1.78B $2.01B $1.46B $1.35B $1.19B $1.17B $1.11B
Current Assets 10-point trend, +73.7% $15.78B $16.41B $14.93B $13.64B $13.54B $12.33B $11.20B $10.21B $9.98B $9.09B
PP&E (Net) 10-point trend, +90.4% $31.14B $29.41B $27.71B $25.57B $24.06B $23.20B $22.71B $19.76B $17.89B $16.35B
PP&E (Gross) 10-point trend, +78.9% $66.28B $62.51B $58.55B $54.76B $51.35B $49.32B $47.23B $42.97B $40.08B $37.05B
Accum. Depreciation 10-point trend, +69.7% $35.13B $33.10B $30.83B $29.18B $27.29B $26.12B $24.52B $23.21B $22.19B $20.70B
Other Non-current Assets 10-point trend, -76.3% $255M $230M $184M $298M $598M $546M $480M $690M $710M $1.07B
Total Assets 10-point trend, +79.9% $60.72B $59.51B $56.21B $52.44B $50.74B $47.49B $45.06B $39.21B $36.59B $33.76B
Accounts Payable 10-point trend, +101.0% $4.66B $4.28B $4.23B $4.24B $4.11B $3.54B $2.90B $2.58B $2.61B $2.32B
Current Liabilities 10-point trend, +180.3% $16.35B $15.18B $12.65B $9.90B $9.58B $8.70B $7.76B $7.57B $6.16B $5.83B
Capital Leases 7-point trend, +23.6% $1.85B $1.86B $1.90B $1.75B $1.75B $1.67B $1.50B · · ·
Total Liabilities 4-point trend, +15.8% · · · · · · $45.62B $42.12B $41.59B $39.39B
Long-term Debt 10-point trend, +41.1% $44.28B $43.03B $39.59B $38.08B $34.58B $31.00B $33.72B $32.82B $33.06B $31.38B
Total Debt 10-point trend, +32.6% $41.60B $43.03B $39.59B $38.08B $34.58B $31.00B $33.72B $32.82B $33.06B $31.38B
Retained Earnings 10-point trend, +17.9% $-5.72B $-2.12B $-1.35B $-2.28B $-532M $777M $-2.35B $-4.57B $-6.53B $-6.97B
AOCI 10-point trend, +9.8% $-305M $-387M $-425M $-490M $-404M $-502M $-460M $-381M $-278M $-338M
Stockholders' Equity 10-point trend, +17.5% $-6.03B $-2.50B $-1.77B $-2.77B $-933M $572M $-2.81B $-4.95B $-6.81B $-7.30B
Liabilities + Equity 10-point trend, +79.9% $60.72B $59.51B $56.21B $52.44B $50.74B $47.49B $45.06B $39.21B $36.59B $33.76B
Shares Outstanding 10-point trend, -39.4% 224,605,100 249,981,400 265,537,300 277,378,300 305,476,800 339,425,600 338,445,600 342,895,200 350,091,600 370,535,900
Przepływy pieniężne 17
Dane roczne Przepływy pieniężne dla HCA
Wskaźnik Trend 2025202420232022202120202019201820172016
D&A 10-point trend, +79.2% $3.52B $3.31B $3.08B $2.97B $2.85B $2.72B $2.60B $2.28B $2.13B $1.97B
Stock-based Comp 10-point trend, +59.8% $401M $360M $262M $341M $440M $362M $347M $268M $270M $251M
Amort. of Intangibles 6-point trend, -53.8% $12M $16M $20M $44M $25M $26M · · · ·
Other Non-cash 10-point trend, +172.2% $1.93B $1.08B $850M $-431M $-1.29B $2.40B $1.07B $461M $-3.53B $-2.67B
Operating Cash Flow 10-point trend, +123.5% $12.64B $10.51B $9.43B $8.52B $8.96B $9.23B $7.60B $6.76B $5.43B $5.65B
CapEx 10-point trend, +79.1% $4.94B $4.88B $4.74B $4.39B $3.58B $2.83B $4.16B $3.57B $3.02B $2.76B
Investing Cash Flow 10-point trend, -54.0% $-4.99B $-4.93B $-5.32B $-3.39B $-2.64B $-3.39B $-5.72B $-3.90B $-4.28B $-3.24B
Debt Issued 10-point trend, +56.9% $8.47B $7.50B $3.22B $6.00B $4.34B $2.70B $6.45B $2.00B $1.50B $5.40B
Net Debt Issued 10-point trend, +17.3% $1.08B $5.08B $2.31B $3.17B $475M $-737M $1.13B $296M $749M $925M
Stock Repurchased 10-point trend, +265.9% $10.07B $6.04B $3.81B $7.00B $8.21B $441M $1.03B $1.53B $2.05B $2.75B
Net Stock Activity 10-point trend, -265.9% $-10.07B $-6.04B $-3.81B $-7.00B $-8.21B $-441M $-1.03B $-1.53B $-2.05B $-2.75B
Dividends Paid 9-point trend, +679000000.00 $679M $690M $661M $653M $624M $153M $550M $487M $0 ·
Financing Cash Flow 10-point trend, -240.9% $-8.55B $-4.58B $-4.09B $-5.66B $-6.66B $-4.68B $-1.77B $-3.08B $-1.06B $-2.51B
Net Change in Cash 10-point trend, -840.0% $-893M $998M $27M $-543M $-342M $1.17B $119M $-230M $86M $-95M
Taxes Paid 10-point trend, +38.6% $1.74B $1.84B $1.39B $1.18B $2.18B $1.00B $849M $872M $1.21B $1.25B
Free Cash Flow 10-point trend, +165.9% $7.69B $5.64B $4.69B $4.13B $5.38B $6.40B $3.44B $3.19B $2.41B $2.89B
Levered FCF 10-point trend, +253.0% $5.91B $4.03B $3.16B $2.74B $4.15B $5.12B $2.00B $1.74B $1.35B $1.68B
Rentowność 5
Dane roczne Rentowność dla HCA
Wskaźnik Trend 2025202420232022202120202019201820172016
Net Margin 8-point trend, +10.6% 9.0% 8.2% 8.1% 9.4% 11.8% 7.3% 6.8% 8.1% · ·
Pretax Margin 8-point trend, +13.8% 13.0% 12.1% 11.9% 14.2% 16.7% 10.5% 10.2% 11.4% · ·
EBITDA Margin 8-point trend, -4.5% 4.7% 4.7% 4.7% 4.9% 4.9% 5.3% 5.1% 4.9% · ·
ROA 10-point trend, +29.8% 11.3% 10.0% 9.7% 10.9% 14.2% 8.1% 8.3% 10.0% 6.3% 8.7%
ROE 10-point trend, -310.3% -159.1% -269.6% -230.9% -305.0% -3853.7% -335.8% -90.4% -64.4% -31.4% -38.8%
Płynność i wypłacalność 4
Dane roczne Płynność i wypłacalność dla HCA
Wskaźnik Trend 2025202420232022202120202019201820172016
Current Ratio 10-point trend, -38.0% 1.0 1.1 1.2 1.4 1.4 1.4 1.4 1.3 1.6 1.6
Quick Ratio 10-point trend, -34.8% 0.7 0.8 0.9 1.0 1.0 1.0 1.1 1.0 1.2 1.1
Debt / Equity 10-point trend, -60.6% -6.9 -17.2 -22.3 -13.8 -37.1 54.2 -12.0 -6.6 -4.9 -4.3
LT Debt / Equity 10-point trend, -61.8% -6.9 -15.3 -21.0 -13.6 -36.8 53.8 -12.0 -6.5 -4.8 -4.3
Efektywność 2
Dane roczne Efektywność dla HCA
Wskaźnik Trend 2025202420232022202120202019201820172016
Asset Turnover 8-point trend, +2.1% 1.3 1.2 1.2 1.2 1.2 1.1 1.2 1.2 · ·
Receivables Turnover 8-point trend, -0.4% 7.0 6.8 6.9 7.1 7.8 7.1 7.2 7.0 · ·
Na akcję 6
Dane roczne Na akcję dla HCA
Wskaźnik Trend 2025202420232022202120202019201820172016
Book Value / Share 10-point trend, -36.2% $-26.83 $-10.00 $-6.68 $-9.98 $-3.05 $1.69 $-8.30 $-14.44 $-19.44 $-19.71
Revenue / Share 8-point trend, +140.3% $315.66 $269.68 $235.04 $204.41 $178.71 $149.98 $147.42 $131.37 · ·
Cash Flow / Share 10-point trend, +269.5% $52.76 $40.16 $34.12 $28.92 $27.25 $26.87 $21.83 $19.03 $14.58 $14.28
Cash / Share 10-point trend, +165.6% $4.63 $7.73 $3.52 $3.27 $4.75 $5.28 $1.83 $1.46 $2.09 $1.74
Dividend / Share 8-point trend, +105.7% $3 $3 $2 $2 $2 $0 $2 $1 · ·
EPS (TTM) 10-point trend, +288.1% $28.33 $22.00 $18.97 $19.15 $21.16 $10.93 $10.07 $10.66 $5.95 $7.30
Stopy Wzrostu 10
Dane roczne Stopy Wzrostu dla HCA
Wskaźnik Trend 2025202420232022202120202019201820172016
Revenue YoY 5-point trend, -49.5% 7.1% 8.7% 7.9% 2.5% 14.0% · · · · ·
Revenue CAGR 3Y 3-point trend, -2.0% 7.9% 6.3% 8.0% · · · · · · ·
Revenue CAGR 5Y 8.0% · · · · · · · · ·
EPS YoY 5-point trend, -69.3% 28.8% 16.0% -0.94% -9.5% 93.6% · · · · ·
EPS CAGR 3Y 3-point trend, -30.9% 13.9% 1.3% 20.2% · · · · · · ·
EPS CAGR 5Y 21.0% · · · · · · · · ·
Net Income YoY 5-point trend, -79.2% 17.8% 9.9% -7.1% -18.9% 85.3% · · · · ·
Net Income CAGR 3Y 3-point trend, -46.2% 6.3% -6.1% 11.8% · · · · · · ·
Net Income CAGR 5Y 12.6% · · · · · · · · ·
Dividend CAGR 5Y 34.7% · · · · · · · · ·
Wycena (TTM) 17
Dane roczne Wycena (TTM) dla HCA
Wskaźnik Trend 2025202420232022202120202019201820172016
Revenue TTM 10-point trend, +82.2% $75.60B $70.60B $64.97B $60.23B $58.75B $51.53B $51.34B $46.68B $43.61B $41.49B
Net Income TTM 10-point trend, +134.7% $6.78B $5.76B $5.24B $5.64B $6.96B $3.75B $3.50B $3.79B $2.22B $2.89B
Market Cap 10-point trend, +282.3% $104.86B $75.03B $71.88B $66.56B $78.48B $55.82B $50.03B $42.67B $30.75B $27.43B
Enterprise Value 10-point trend, +150.3% $145.42B $116.13B $110.53B $103.74B $111.61B $84.92B $82.98B $74.95B $63.02B $58.11B
P/E 10-point trend, +62.5% 16.5 13.6 14.3 12.5 12.1 15.0 14.7 11.7 14.8 10.1
P/S 10-point trend, +109.8% 1.4 1.1 1.1 1.1 1.3 1.1 1.0 0.9 0.7 0.7
P/B 10-point trend, -363.2% -17.4 -30.0 -40.5 -24.1 -84.1 97.6 -17.8 -8.6 -4.5 -3.8
P / Tangible Book · · · · · 97.6 · · · ·
P / Cash Flow 10-point trend, +71.0% 8.3 7.1 7.6 7.8 8.8 6.0 6.6 6.3 5.7 4.9
P / FCF 10-point trend, +43.8% 13.6 13.3 15.3 16.1 14.6 8.7 14.5 13.4 12.8 9.5
EV / EBITDA 10-point trend, +39.7% 41.3 35.1 35.9 34.9 39.1 31.2 32.0 32.9 29.6 29.6
EV / FCF 10-point trend, -5.9% 18.9 20.6 23.6 25.1 20.7 13.3 24.1 23.5 26.1 20.1
EV / Revenue 10-point trend, +37.4% 1.9 1.6 1.7 1.7 1.9 1.6 1.6 1.6 1.4 1.4
Dividend Yield 9-point trend, +0.01 0.65% 0.92% 0.92% 0.98% 0.80% 0.27% 1.1% 1.1% 0.00% ·
Earnings Yield 10-point trend, -38.4% 6.1% 7.3% 7.0% 8.0% 8.2% 6.7% 6.8% 8.6% 6.8% 9.9%
Payout Ratio 8-point trend, -22.2% 10.0% 12.0% 12.6% 11.6% 9.0% 4.1% 15.7% 12.9% · ·
Annual Payout 9-point trend, +679000000.00 $679M $690M $661M $653M $624M $153M $550M $487M $0 ·

Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat

Rachunek zysków i strat
2025-12-312024-12-312023-12-312022-12-312021-12-31
Przychody $75.60B$70.60B$64.97B$60.23B$58.75B
Zysk netto $6.78B$5.76B$5.24B$5.64B$6.96B
Rozwodniony EPS $28.33$22.00$18.97$19.15$21.16
Bilans
2025-12-312024-12-312023-12-312022-12-312021-12-31
Dług / Kapitał Własny -6.9-17.2-22.3-13.8-37.1
Wskaźnik bieżący 1.01.11.21.41.4
Wskaźnik Szybkości 0.70.80.91.01.0
Przepływy pieniężne
2025-12-312024-12-312023-12-312022-12-312021-12-31
Wolny przepływ pieniężny $7.69B$5.64B$4.69B$4.13B$5.38B

Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie

Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów

📊

Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.

Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.

Właściciele instytucjonalni (13F) 1 486 emitentów · $39.4B łącznie · Na dzień 30 czerwca 2026

Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.

Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
Nowe pozycje Zamknięte pozycje Zwiększone Zmniejszony Zmiana liczby akcji netto
128 (-51 vs poprzedni kw.) 174 (+70 vs poprzedni kw.) 450 (-30 vs poprzedni kw.) 555 (-4 vs poprzedni kw.) +16.3M

Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.

Instytucja Wartość Akcje % z śledzonych 13F Typ
VANGUARD GROUP INC $6 118 113 464 13 104 814 15,52% Akcje
VANGUARD CAPITAL MANAGEMENT LLC $3 954 150 533 10 141 708 10,03% Akcje
Sanders Capital, LLC $3 442 060 818 8 828 287 8,73% Akcje
STATE STREET CORP $2 912 102 056 7 469 035 7,39% Akcje
WELLINGTON MANAGEMENT GROUP LLP $1 750 298 867 4 489 212 4,44% Akcje
GEODE CAPITAL MANAGEMENT, LLC $1 225 259 672 3 159 159 3,11% Akcje
VANGUARD PORTFOLIO MANAGEMENT LLC $1 057 704 509 2 712 828 2,68% Akcje
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $861 456 107 2 209 485 2,19% Akcje
NORGES BANK $836 457 140 2 145 367 2,12% Akcje
Capital World Investors $770 864 224 1 977 121 1,96% Akcje
Capital International Investors $747 403 041 1 916 947 1,90% Akcje
Crake Asset Management LLP $449 072 183 1 151 792 1,14% Akcje
Metropolis Capital Ltd $430 915 307 910 564 1,09% Akcje
Darsana Capital Partners LP $428 879 000 1 100 000 1,09% Akcje
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $414 533 777 1 063 207 1,05% Akcje
Life Cycle Investment Partners Ltd $355 737 196 912 404 0,90% Akcje
VANGUARD FIDUCIARY TRUST CO $339 685 814 871 235 0,86% Akcje
FMR LLC $325 199 295 834 080 0,83% Akcje
BARCLAYS PLC $299 888 573 769 162 0,76% Akcje
LYRICAL ASSET MANAGEMENT LP $255 015 742 654 071 0,65% Akcje
BlackRock, Inc. $240 062 291 615 718 0,61% Akcje
ROYAL LONDON ASSET MANAGEMENT LTD $235 649 908 604 401 0,60% Akcje
National Pension Service $230 650 346 591 578 0,59% Akcje
NORDEA INVESTMENT MANAGEMENT AB $230 189 125 594 466 0,58% Akcje
GOLDMAN SACHS GROUP INC $209 775 669 538 038 0,53% Akcje
Gobi Capital LLC $195 742 325 502 045 0,50% Akcje
Cryder Capital Partners LLP $194 561 738 499 017 0,49% Akcje
Swiss National Bank $172 097 446 441 400 0,44% Akcje
AustralianSuper Pty Ltd $159 635 782 409 438 0,41% Akcje
Consulta Ltd $155 956 000 400 000 0,40% Akcje
LEE DANNER & BASS INC $152 150 679 390 240 0,39% Akcje
SUSQUEHANNA INTERNATIONAL GROUP, LLP $151 472 265 388 500 0,38% Opcja kupna
Mitsubishi UFJ Asset Management Co., Ltd. $147 943 761 379 450 0,38% Akcje
DIMENSIONAL FUND ADVISORS LP $139 697 405 358 300 0,35% Akcje
Vanguard Global Advisers, LLC $136 962 509 351 285 0,35% Akcje
VIRGINIA RETIREMENT SYSTEMS ET Al $134 838 505 288 820 0,34% Akcje
ALLIANCEBERNSTEIN L.P. $134 459 788 284 126 0,34% Akcje
Sumitomo Mitsui Trust Group, Inc. $132 794 974 340 596 0,34% Akcje
TD Asset Management Inc $131 847 152 338 165 0,33% Akcje
Legal & General Group Plc $127 805 162 327 798 0,32% Akcje
California Public Employees Retirement System $124 133 958 318 382 0,31% Akcje
LAZARD ASSET MANAGEMENT LLC $120 619 879 309 369 0,31% Akcje
JANE STREET GROUP, LLC $119 540 274 306 600 0,30% Opcja kupna
VANGUARD ASSET MANAGEMENT, Ltd $116 069 863 297 699 0,29% Akcje
CAPTRUST FINANCIAL ADVISORS $114 741 071 294 291 0,29% Akcje
ANTIPODES PARTNERS Ltd $113 045 096 289 941 0,29% Akcje
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $109 718 328 231 845 0,28% Akcje
CITADEL ADVISORS LLC $105 660 190 271 000 0,27% Opcja kupna
RHUMBLINE ADVISERS $97 580 413 250 277 0,25% Akcje
O'SHAUGHNESSY ASSET MANAGEMENT, LLC $97 026 076 248 855 0,25% Akcje
MACKENZIE FINANCIAL CORP $93 597 383 240 061 0,24% Akcje
BloombergSen Inc. $93 160 317 238 940 0,24% Akcje
SUSQUEHANNA INTERNATIONAL GROUP, LLP $92 247 974 236 600 0,23% Opcja sprzedaży
Brandywine Global Investment Management, LLC $89 380 814 191 451 0,23% Akcje
BANK OF AMERICA CORP /DE/ $89 069 981 228 449 0,23% Akcje
NEUBERGER BERMAN GROUP LLC $85 926 216 220 386 0,22% Akcje
MILFORD FUNDS LTD $82 165 029 210 739 0,21% Akcje
Bridgewater Associates, LP $79 227 208 203 204 0,20% Akcje
Prana Capital Management, LP $75 552 494 193 779 0,19% Akcje
DANSKE BANK A/S $73 238 497 187 844 0,19% Akcje
FRANKLIN RESOURCES INC $70 965 828 182 015 0,18% Akcje
VOLORIDGE INVESTMENT MANAGEMENT, LLC $70 445 715 180 681 0,18% Akcje
Quantinno Capital Management LP $70 407 055 180 581 0,18% Akcje
ARGENT CAPITAL MANAGEMENT LLC $69 149 681 177 357 0,18% Akcje
Retirement Systems of Alabama $68 081 812 174 618 0,17% Akcje
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND $66 167 842 169 709 0,17% Akcje
BNP PARIBAS FINANCIAL MARKETS $64 793 090 166 183 0,16% Akcje
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $64 665 206 165 855 0,16% Akcje
HSBC HOLDINGS PLC $64 431 534 165 332 0,16% Akcje
AVIVA PLC $64 264 789 164 828 0,16% Akcje
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $64 194 533 135 649 0,16% Akcje
SEB Asset Management AB $63 257 255 162 244 0,16% Akcje
TODD ASSET MANAGEMENT LLC $62 567 208 160 474 0,16% Akcje
Swedbank AB $62 528 998 160 376 0,16% Akcje
W1M Investment Management Ltd $61 247 490 143 647 0,16% Akcje
HARRIS ASSOCIATES L P $60 080 879 154 097 0,15% Akcje
Ensign Peak Advisors, Inc $58 372 381 149 715 0,15% Akcje
NEW YORK STATE COMMON RETIREMENT FUND $57 747 778 148 113 0,15% Akcje
CITADEL ADVISORS LLC $57 235 852 146 800 0,15% Opcja sprzedaży
Universal- Beteiligungs- und Servicegesellschaft mbH $57 160 993 146 800 0,15% Akcje
LOS ANGELES CAPITAL MANAGEMENT LLC $56 512 217 144 944 0,14% Akcje
Pictet Asset Management Holding SA $52 147 803 133 739 0,13% Akcje
VICTORY CAPITAL MANAGEMENT INC $50 752 761 130 172 0,13% Akcje
Pentwater Capital Management LP $50 685 700 130 000 0,13% Akcje
D. E. Shaw & Co., Inc. $50 554 307 129 663 0,13% Akcje
APG Asset Management N.V. $50 368 550 147 699 0,13% Akcje
AMF Tjanstepension AB $50 355 853 129 154 0,13% Akcje
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM $50 349 225 129 137 0,13% Akcje
EQUITABLE TRUST CO $49 147 974 126 056 0,12% Akcje
ENVESTNET ASSET MANAGEMENT INC $48 919 124 125 469 0,12% Akcje
CANADA PENSION PLAN INVESTMENT BOARD $48 197 812 123 619 0,12% Akcje
AMERICAN CENTURY COMPANIES INC $47 460 140 121 727 0,12% Akcje
OpenArc Corporate Advisory, LLC $47 210 610 121 087 0,12% Akcje
L1 Capital International Pty Ltd $46 121 648 118 294 0,12% Akcje
FIRST TRUST ADVISORS LP $44 251 579 113 498 0,11% Akcje
PFA Pension, Forsikringsaktieselskab $44 046 098 112 971 0,11% Akcje
United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund $43 830 264 112 417 0,11% Akcje
EP Wealth Advisors, LLC $43 287 826 111 026 0,11% Akcje
WOLVERINE TRADING, LLC $42 597 104 101 200 0,11% Opcja kupna
MERCER GLOBAL ADVISORS INC /ADV $42 302 070 108 497 0,11% Akcje

Insiderzy spółki 91 insiderów · 54 dyrektorzy generalni · 31 dyrektorzy

Insider Rola Ostatnia aktywność Posiadane akcje Kupna 12m Sprzedaże 12m Netto 12m
Samuel N Hazen CEO 10 lutego 2026 F 64 842 0 7 $-21 483 290
O'Boyle Michael P President & CEO - Parallon 26 lutego 2013 A 21 429 0 0 $0
Mike A Marks EVP and CFO 7 maja 2026 G 46 576 0 0 $0
Bill B Rutherford CFO and EVP 16 lutego 2024 F 22 251 0 0 $0
Russell K Harms CFO - Central Group 17 listopada 2006 D 0 0 0 $0
Robert Samuel Hankins JR CFO-Outpatient Services Group 17 listopada 2006 D 0 0 0 $0
Richard J Shallcross CFO - Western Group 17 listopada 2006 D 0 0 0 $0
Jeffrey T Crudele CFO-Eastern Division 1 lipca 2005 F 13 865 0 0 $0
Erol R Akdamar Group President 12 listopada 2024 M 6 843 0 0 $0
Timothy M Mcmanus Group President 31 lipca 2024 M 27 008 0 0 $0
Richard A Hammett Group President 16 lutego 2024 F 17 936 0 0 $0
Charles J Hall Group President 11 listopada 2022 M 202 443 0 0 $0
Bruce A Moore JR Group President - Service Line 11 listopada 2022 S 30 807 0 0 $0
Paul W Rutledge Group President 31 grudnia 2012 A 335 657 0 0 $0
Beverly B Wallace President - Parallon 2 listopada 2011 M 144 714 0 0 $0
Charles Robert Evans President - Eastern Group 26 lipca 2006 A 62 173 0 0 $0
Marilyn B Tavenner President-Outpatient Svcs Grp 27 października 2005 A 26 154 0 0 $0
Greg Roth President-Ambulatory Surgery 31 października 2004 D 9 029 0 0 $0
Jay Grinney President-Eastern Group 7 maja 2004 D 24 177 0 0 $0
Jon M Foster EVP and COO 10 lutego 2026 F 23 062 0 0 $0
Michael R Mcalevey EVP & Chief Legal & Admin Off. 13 lutego 2026 M 8 853 0 2 $-2 747 520
Jennifer Berres SVP & Chief Human Res. Officer 11 lutego 2026 S 11 993 0 2 $-4 126 932
Christopher F. Wyatt SVP & Controller 11 lutego 2026 S 44 379 0 1 $-2 020 000
Erica Rossitto SVP & Chief Nurse Executive 10 lutego 2026 F 10 407 0 0 $0
Michael S. Cuffe EVP and Chief Clinical Officer 10 lutego 2026 F 32 080 0 1 $-747 135
Sammie S Mosier SVP & Chief Nurse Executive 13 lutego 2025 F 11 113 0 0 $0
Kathleen M Whalen SVP & Chief Ethics Officer 14 listopada 2024 S 9 454 0 0 $0
Phillip G Billington SVP-Internal Audit Services 12 listopada 2024 M 52 702 0 0 $0
Joseph A Sowell III SVP; Chief Development Officer 5 sierpnia 2024 G 18 526 0 0 $0
Deborah M Reiner SVP - Mktg. & Communications 29 lipca 2024 S 3 510 0 0 $0
Kathryn A. Torres SVP-Payer Contracting & Align. 25 lipca 2024 S 17 755 0 0 $0
Jeffrey E. Cohen SVP-Government Relations 9 maja 2024 S 5 185 0 0 $0
Chad J Wasserman SVP and CIO 18 marca 2024 M 1 576 0 0 $0
Martin P. Paslick SVP and CIO 12 kwietnia 2023 M 24 643 0 0 $0
Jane D. Englebright SVP and Chief Nursing Officer 9 listopada 2021 S 0 0 0 $0
Robert A Waterman SVP & General Counsel 5 maja 2021 S 50 062 0 0 $0
William J Morrow SVP - Finance and Treasurer 18 lutego 2021 F 5 578 0 0 $0
Sandra L. Morgan SVP-Provider Relations 18 lutego 2021 F 10 122 0 0 $0
Victor L Campbell SVP-Government Affairs 1 maja 2019 A 194 145 0 0 $0
John M Steele SVP & Chief Human Res. Officer 25 lutego 2019 M 84 157 0 0 $0
Milton R Johnson Chairman 25 lutego 2019 M 881 823 0 0 $0
Ravi S. Chari SVP-Clinical Excellence 25 lutego 2018 M 7 003 0 0 $0
Alan R Yuspeh SVP & Chief Ethics Officer 25 lutego 2018 M 35 546 0 0 $0
Joseph N Steakley SVP-Internal Audit Services 25 lutego 2018 M 65 199 0 0 $0
Jana Joustra Davis SVP - Mktg. & Corp. Affairs 23 maja 2017 M 26 378 0 0 $0
David Gwin Anderson SVP - Finance 7 listopada 2016 M 110 167 0 0 $0
Donald W Stinnett SVP & Controller 25 lutego 2016 A 51 965 0 0 $0
Noel B Williams SVP and CIO 16 maja 2012 M 299 030 0 0 $0
Jack O Bovender JR Chairman 6 października 2009 A 188 340 0 0 $0
Carl V George SVP - Development 27 lutego 2009 M 13 092 0 0 $0

Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S

Aktywiści i właściciele 5%+ 4 akcje

Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.

Zgłaszający Złożono Udział Status Cel Zgłoszenie
Frisco Holding II, Hercules Holding II, Thomas F. Frist, Jr., Thomas F. Frist III, William R. Frist, Patricia F. Elcan 10 lutego 2026 31,60% Pierwotne zgłoszenie SEC
22 listopada 2006 Pierwotne zgłoszenie SEC
Merrill Lynch Bank USA 11 września 2006 Pierwotne zgłoszenie SEC
Frisco, Inc., Frisco Partners, Thomas F. Frist, Jr., Patricia Champion Frist, Patricia Frist Elcan, William Robert Frist, Thomas F. Frist III, Merrill Lynch Professional Clearing Corp., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Merrill Lynch Financial Markets, Inc., Merrill Lynch International, Merrill Lynch & Co., Inc., Merrill Lynch Trust Company, FSB, Citigroup Inc.*, Bank of America Corporation, NB Holdings Corporation, NationsBanc Montgomery Holdings Corporation, Banc of America Securities LLC 4 sierpnia 2006 Pierwotne zgłoszenie SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Posiadanie ETF-ów Posiadane przez 207 funduszy ETF

Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.

Fundusz Waga Jednostki Na dzień Źródło
IHF · iShares Trust 4,67% 141 320 SH 8 sierpnia 2026 Dziennie
BUL · Pacer Funds Trust 3,91% 11 437 NS 30 kwietnia 2026 N-PORT
YALL · Tidal Trust I 3,61% 9 261 NS 31 maja 2026 N-PORT
BWTG · ETF Opportunities Trust 3,02% 1 646 NS 31 maja 2026 N-PORT
PKW · Invesco Exchange-Traded Fund Trust 2,32% 99 335 SH 8 sierpnia 2026 Dziennie
ABIG · EA Series Trust 2,00% 2 938 NS 29 maja 2026 N-PORT
FXH · First Trust Exchange-Traded AlphaDE… 1,99% 39 985 NS 30 kwietnia 2026 N-PORT
RSPH · Invesco Exchange-Traded Fund Trust 1,67% 31 685 SH 8 sierpnia 2026 Dziennie
COWZ · Pacer Funds Trust 1,64% 688 264 NS 30 kwietnia 2026 N-PORT
QQWZ · Pacer Funds Trust 1,64% 1 762 NS 30 kwietnia 2026 N-PORT
FEGE · RBB Fund Trust 1,46% 74 706 NS 31 maja 2026 N-PORT
PWV · Invesco Exchange-Traded Fund Trust 1,39% 60 385 SH 8 sierpnia 2026 Dziennie
RPG · Invesco Exchange-Traded Fund Trust 1,30% 63 448 SH 8 sierpnia 2026 Dziennie
TMFE · RBB Fund, Inc. 1,29% 2 892 NS 31 maja 2026 N-PORT
AMID · EA Series Trust 1,23% 3 402 NS 29 maja 2026 N-PORT
FCPI · FIDELITY COVINGTON TRUST 1,15% 7 180 NS 30 kwietnia 2026 N-PORT
FMAG · FIDELITY COVINGTON TRUST 1,12% 6 544 NS 30 kwietnia 2026 N-PORT
FHLC · FIDELITY COVINGTON TRUST 1,12% 73 639 NS 30 kwietnia 2026 N-PORT
SRHQ · Elevation Series Trust 1,10% 4 883 NS 30 kwietnia 2026 N-PORT
IYH · iShares Trust 0,99% 89 420 SH 8 sierpnia 2026 Dziennie
NEAR · iShares U.S. ETF Trust 0,99% 48 109 000 SH 8 sierpnia 2026 Dziennie
CURE · Direxion Shares ETF Trust 0,98% 3 122 NS 30 kwietnia 2026 N-PORT
VHT · VANGUARD WORLD FUND 0,90% 470 451 SH 8 sierpnia 2026 Dziennie
NFRA · FlexShares Trust 0,88% 62 176 NS 30 kwietnia 2026 N-PORT
REVS · Columbia ETF Trust I 0,87% 5 693 NS 30 kwietnia 2026 N-PORT
RXL · ProShares Trust 0,86% 1 632 NS 31 maja 2026 N-PORT
DIVB · iShares Trust 0,85% 36 806 SH 8 sierpnia 2026 Dziennie
BSCT · Invesco Exchange-Traded Self-Indexe… 0,82% 24 078 000 8 sierpnia 2026 Dziennie
LSEQ · Harbor ETF Trust 0,81% 285 NS 30 kwietnia 2026 N-PORT
IXJ · iShares Trust 0,80% 81 465 SH 8 sierpnia 2026 Dziennie
BSCS · Invesco Exchange-Traded Self-Indexe… 0,76% 26 493 000 8 sierpnia 2026 Dziennie
SPVM · Invesco Exchange-Traded Fund Trust 0,74% 2 335 SH 8 sierpnia 2026 Dziennie
FTC · First Trust Exchange-Traded AlphaDE… 0,73% 21 329 NS 30 kwietnia 2026 N-PORT
RFFC · ALPS ETF Trust 0,68% 533 NS 31 maja 2026 N-PORT
QUVU · Hartford Funds Exchange-Traded Trust 0,68% 2 698 NS 30 kwietnia 2026 N-PORT
VFMF · VANGUARD WELLINGTON FUND 0,67% 12 075 SH 8 sierpnia 2026 Dziennie
VCEB · VANGUARD WORLD FUND 0,62% 8 146 000 PA 8 sierpnia 2026 Dziennie
FDMO · FIDELITY COVINGTON TRUST 0,61% 11 771 NS 30 kwietnia 2026 N-PORT
RECS · Columbia ETF Trust I 0,58% 72 768 NS 30 kwietnia 2026 N-PORT
AFLG · First Trust Exchange-Traded Fund VI… 0,56% 9 664 NS 31 maja 2026 N-PORT
VFVA · VANGUARD WELLINGTON FUND 0,55% 11 876 SH 8 sierpnia 2026 Dziennie
VLLU · Harbor ETF Trust 0,54% 54 NS 30 kwietnia 2026 N-PORT
LSVD · ADVISORS' INNER CIRCLE FUND 0,53% 7 404 NS 30 kwietnia 2026 N-PORT
WLDR · Two Roads Shared Trust 0,51% 844 NS 30 kwietnia 2026 N-PORT
VALQ · AMERICAN CENTURY ETF TRUST 0,50% 4 620 NS 31 maja 2026 N-PORT
AKAF · ETF Series Solutions 0,50% 39 NS 31 maja 2026 N-PORT
BSCR · Invesco Exchange-Traded Self-Indexe… 0,50% 22 679 000 8 sierpnia 2026 Dziennie
ROUS · Lattice Strategies Trust 0,47% 6 388 NS 30 kwietnia 2026 N-PORT
VCLT · VANGUARD SCOTTSDALE FUNDS 0,46% 54 218 000 PA 8 sierpnia 2026 Dziennie
CGGR · Capital Group Growth ETF 0,45% 290 273 NS 31 maja 2026 N-PORT